Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (åbner nyt vindue)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Kilde‎: Br J Haematol 2013;161(5):738-40.

Indekseret‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (åbner nyt vindue)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. (åbner nyt vindue)

Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ

Kilde‎: Haematologica 2021;106(4):1148-57.

Indekseret‎: PubMed 32499239

DOI‎: 10.3324/haematol.2020.251900

https://www.ncbi.nlm.nih.gov/pubmed/32499239 (åbner nyt vindue)

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. (åbner nyt vindue)

Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J.

Kilde‎: Cancer 2008;113(6):1338-43.

Indekseret‎: PubMed 18629842

DOI‎: 10.1002/cncr.23718

https://www.ncbi.nlm.nih.gov/pubmed/18629842 (åbner nyt vindue)

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia. (åbner nyt vindue)

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Kilde‎: Transfusion 2012;52(4):739-41.

Indekseret‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

https://www.ncbi.nlm.nih.gov/pubmed/22082044 (åbner nyt vindue)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (åbner nyt vindue)

Bhatia M, Davenport V, Cairo MS.

Kilde‎: Leuk Lymphoma 2007;48(1):9-15.

Indekseret‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (åbner nyt vindue)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide. (åbner nyt vindue)

Chawla SP, Staddon A, Hendifar A, Messam CA, Patwardhan R, Kamel YM.

Kilde‎: BMC Cancer 2013;13:121.

Indekseret‎: PubMed 23497336

DOI‎: 10.1186/1471-2407-13-121

https://www.ncbi.nlm.nih.gov/pubmed/23497336 (åbner nyt vindue)

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. (åbner nyt vindue)

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Kilde‎: Pathol Oncol Res 2011;17(1):141-3.

Indekseret‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

https://www.ncbi.nlm.nih.gov/pubmed/20628840 (åbner nyt vindue)

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. (åbner nyt vindue)

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Kilde‎: J Neurooncol 2012;106(2):427-9.

Indekseret‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

https://www.ncbi.nlm.nih.gov/pubmed/21833801 (åbner nyt vindue)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (åbner nyt vindue)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Kilde‎: Lancet 2003;361(9354):275-80.

Indekseret‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (åbner nyt vindue)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (åbner nyt vindue)

Ford PA, Grant SJ, Mick R, Keck G.

Kilde‎: J Clin Oncol 2015;33(15):1674-9.

Indekseret‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (åbner nyt vindue)

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. (åbner nyt vindue)

Gao Y, Liu Q, Shen Y, Li Y, Shao K, Ye B, Shen Y, Zhou Y, Wu D

Kilde‎: Platelets. 2022 3;33(7):1024-1030.

Indekseret‎: PubMed 35040375

DOI‎: 10.1080/09537104.2022.2026910

https://pubmed.ncbi.nlm.nih.gov/35040375/ (åbner nyt vindue)

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (åbner nyt vindue)

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Kilde‎: Cancer 2014;120(12):1838-46.

Indekseret‎: PubMed 24706489

DOI‎: 10.1002/cncr.28663

https://www.ncbi.nlm.nih.gov/pubmed/24706489 (åbner nyt vindue)

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. (åbner nyt vindue)

Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J.

Kilde‎: Leuk Lymphoma 2013;54(2):321-8.

Indekseret‎: PubMed 22906162

DOI‎: 10.3109/10428194.2012.713477

https://www.ncbi.nlm.nih.gov/pubmed/22906162 (åbner nyt vindue)

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience. (åbner nyt vindue)

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Kilde‎: Platelets 2012;23(6):423-9.

Indekseret‎: PubMed 22185370

DOI‎: 10.3109/09537104.2011.634931

https://www.ncbi.nlm.nih.gov/pubmed/22185370 (åbner nyt vindue)

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. (åbner nyt vindue)

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Kilde‎: Ann Hematol 2015;94(1):117-28.

Indekseret‎: PubMed 25069650

DOI‎: 10.1007/s00277-014-2158-1

https://www.ncbi.nlm.nih.gov/pubmed/25069650 (åbner nyt vindue)

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. (åbner nyt vindue)

Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ.

Kilde‎: J Hematol Oncol 2015;8:37.

Indekseret‎: PubMed 25886818

DOI‎: 10.1186/s13045-015-0136-2

https://www.ncbi.nlm.nih.gov/pubmed/25886818 (åbner nyt vindue)

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (åbner nyt vindue)

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP.

Kilde‎: J Clin Oncol 2010;28(3):437-44.

Indekseret‎: PubMed 20008626

DOI‎: 10.1200/JCO.2009.24.7999

https://www.ncbi.nlm.nih.gov/pubmed/20008626 (åbner nyt vindue)

The use of simple patient blood management strategies as an alternative to platelet and red cell transfusion in autologous stem cell transplant. (åbner nyt vindue)

Locantore-Ford P, Grant SJ, Keck G.

Kilde‎: Blood 2013;122(21):2140.

https://www.bloodjournal.org/content/122/21/2140 (åbner nyt vindue)

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. (åbner nyt vindue)

Loo M, Beguin Y.

Kilde‎: Blood 1999;93(10):3286-93.

Indekseret‎: PubMed 10233880

https://www.ncbi.nlm.nih.gov/pubmed/10233880 (åbner nyt vindue)

A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia. (åbner nyt vindue)

Miao J, Leblebjian H, Scullion B, Parnes A

Kilde‎: Am J Hematol 2018;93(4):E86-E88.

Indekseret‎: PubMed 29274130

DOI‎: 10.1002/ajh.25022

https://www.ncbi.nlm.nih.gov/pubmed/29274130 (åbner nyt vindue)

Pharmacological therapies to minimise platelet transfusion. (åbner nyt vindue)

Norfolk DR, Seghatchian J.

Kilde‎: Transfus Sci 2000;22(3):149-53.

Indekseret‎: PubMed 10831916

https://www.ncbi.nlm.nih.gov/pubmed/10831916 (åbner nyt vindue)

Romiplostim for management of chemotherapy-induced thrombocytopenia. (åbner nyt vindue)

Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G.

Kilde‎: Support Care Cancer 2014;22(5):1217-22.

Indekseret‎: PubMed 24414994

DOI‎: 10.1007/s00520-013-2074-2

https://www.ncbi.nlm.nih.gov/pubmed/24414994 (åbner nyt vindue)

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. (åbner nyt vindue)

Pathak S, Roth M, Verma A, Steidl U.

Kilde‎: Expert Opin Drug Metab Toxicol 2013;9(12):1667-75.

Indekseret‎: PubMed 24215532

DOI‎: 10.1517/17425255.2013.858119

https://www.ncbi.nlm.nih.gov/pubmed/24215532 (åbner nyt vindue)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (åbner nyt vindue)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Kilde‎: Leuk Lymphoma. 2019;60(9):2324-7.

Indekseret‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (åbner nyt vindue)

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. (åbner nyt vindue)

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Kilde‎: Lancet Haematol 2015;2(10):e417-26.

Indekseret‎: PubMed 26686043

https://www.ncbi.nlm.nih.gov/pubmed/26686043 (åbner nyt vindue)

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. (åbner nyt vindue)

Poon LM, Di Stasi A, Popat U, Champlin RE, Ciurea SO.

Kilde‎: Am J Blood Res 2013;3(3):260-4.

Indekseret‎: PubMed 23997988

https://www.ncbi.nlm.nih.gov/pubmed/23997988 (åbner nyt vindue)

Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. (åbner nyt vindue)

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Kilde‎: Indian J Hematol Blood Transfus 2015;31(4):413-5.

Indekseret‎: PubMed 26306064

DOI‎: 10.1007/s12288-014-0491-0

https://www.ncbi.nlm.nih.gov/pubmed/26306064 (åbner nyt vindue)

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (åbner nyt vindue)

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Kilde‎: Blood 2010;116(12):2127-33.

Indekseret‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

https://www.ncbi.nlm.nih.gov/pubmed/20530792 (åbner nyt vindue)

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. (åbner nyt vindue)

Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U.

Kilde‎: Blood 2012;120(2):386-94.

Indekseret‎: PubMed 22627766

DOI‎: 10.1182/blood-2011-12-399667

https://www.ncbi.nlm.nih.gov/pubmed/22627766 (åbner nyt vindue)

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. (åbner nyt vindue)

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D.

Kilde‎: Cancer 2011;117(5):992-1000.

Indekseret‎: PubMed 20945323

DOI‎: 10.1002/cncr.25545

https://www.ncbi.nlm.nih.gov/pubmed/20945323 (åbner nyt vindue)

Romiplostim treatment of chemotherapy-induced thrombocytopenia. (åbner nyt vindue)

Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S

Kilde‎: J Clin Oncol 2019;37(31):2892-8.

Indekseret‎: PubMed 31545663

DOI‎: 10.1200/JCO.18.01931

https://www.ncbi.nlm.nih.gov/pubmed/31545663 (åbner nyt vindue)

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (åbner nyt vindue)

Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B.

Kilde‎: Blood 2000;95(9):2983-9.

Indekseret‎: PubMed 10779449

https://www.ncbi.nlm.nih.gov/pubmed/10779449 (åbner nyt vindue)

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine. (åbner nyt vindue)

Svensson T, Chowdhury O, Garelius H, Lorenz F, Saft L, Jacobsen SE, Hellström-Lindberg E, Cherif H.

Kilde‎: Eur J Haematol 2014;93(5):439-45.

Indekseret‎: PubMed 24853277

DOI‎: 10.1111/ejh.12383

https://www.ncbi.nlm.nih.gov/pubmed/24853277 (åbner nyt vindue)

Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. (åbner nyt vindue)

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Kilde‎: Biol Blood Marrow Transplant 2016;22(5):919-24.

Indekseret‎: PubMed 26785333

DOI‎: 10.1016/j.bbmt.2016.01.018

https://www.ncbi.nlm.nih.gov/pubmed/26785333 (åbner nyt vindue)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (åbner nyt vindue)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Kilde‎: Ann Oncol 2005;16(1):139-45.

Indekseret‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (åbner nyt vindue)

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. (åbner nyt vindue)

Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS.

Kilde‎: J Hematol Oncol 2012;5:71.

Indekseret‎: PubMed 23190430

DOI‎: 10.1186/1756-8722-5-71

https://www.ncbi.nlm.nih.gov/pubmed/23190430 (åbner nyt vindue)

Romiplostim for chemotherapy-induced thrombocytopenia: efficacy and safety of extended use. (åbner nyt vindue)

Wilkins CR, Ortiz J, Gilbert LJ, Yin S, Mones JV, Parameswaran R, Mantha S, Soff GA

Kilde‎: Res Pract Thromb Haemost. 2022;6(3):e12701.

Indekseret‎: PubMed 35582038

DOI‎: 10.1002/rth2.12701

https://pubmed.ncbi.nlm.nih.gov/35582038/ (åbner nyt vindue)

Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. (åbner nyt vindue)

Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, Aivado MA, Verma A, Steidl U.

Kilde‎: Blood 2009;114(18):3899-908.

Indekseret‎: PubMed 19710504

DOI‎: 10.1182/blood-2009-04-219493

https://www.ncbi.nlm.nih.gov/pubmed/19710504 (åbner nyt vindue)